Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H48O3 |
Molecular Weight | 456.7003 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](OC(=O)CCCCCCCCCCC)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=OXXNTXVXBWLYQE-PVHICTMWSA-N
InChI=1S/C30H48O3/c1-3-4-5-6-7-8-9-10-11-12-29(32)33-28-18-17-27-26-15-13-22-21-23(31)14-16-24(22)25(26)19-20-30(27,28)2/h21,24-28H,3-20H2,1-2H3/t24-,25+,26+,27-,28-,30-/m0/s1
Molecular Formula | C30H48O3 |
Molecular Weight | 456.7003 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.drugs.com/pro/nandrolone.htmlCurator's Comment: Description was created based on several sources, including
https://empower.pharmacy/drugs/nandrolone-decanoate-injection.html
https://us.basicstero.info/nandrolones
Sources: https://www.drugs.com/pro/nandrolone.html
Curator's Comment: Description was created based on several sources, including
https://empower.pharmacy/drugs/nandrolone-decanoate-injection.html
https://us.basicstero.info/nandrolones
Nandrolone, also known as 19-nortestosterone or 19-norandrostenolone, is a semisynthetic anabolic-androgenic steroid derived from testosterone. Nandrolone is used in the form of a variety of long-acting prodrug esters for intramuscular injection, the most common of which are nandrolone decanoate. Nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. Complete dissociation of anabolic and androgenic effects has not been achieved. The actions of anabolic steroids are therefore similar to those of male sex hormones with the possibility of causing serious disturbances of growth and sexual development if given to young children. Anabolic steroids suppress the gonadotropic functions of the pituitary and may exert a direct effect upon the testis. Anabolic steroids have been reported to increase low-density lipoproteins and decrease high-density lipoproteins. Synthetic version of nandrolone was developed in 1950. But nandrolone for sale appeared later only in 1962 in the form of decanoate under the trade name Deca-Durabolin (Organon company).
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P10275 Gene ID: 367.0 Gene Symbol: AR Target Organism: Homo sapiens (Human) |
|||
Target ID: CHEMBL1871 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18809391 |
|||
Target ID: P10275 Gene ID: 367.0 Gene Symbol: AR Target Organism: Homo sapiens (Human) |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | NANDROLONE DECANOATE Approved UseNandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Surgically induced anephric patients have been reported to be less responsive. Launch Date2010 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
36.1 μg/L EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/10435281 |
6 mL single, oral dose: 6 mL route of administration: Oral experiment type: SINGLE co-administered: |
NANDROLONE PHENPROPIONATE blood | Sus scrofa population: HEALTHY age: UNKNOWN sex: FEMALE / MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
219.9 μg × h/L EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/10435281 |
6 mL single, oral dose: 6 mL route of administration: Oral experiment type: SINGLE co-administered: |
NANDROLONE PHENPROPIONATE blood | Sus scrofa population: HEALTHY age: UNKNOWN sex: FEMALE / MALE food status: FASTED |
PubMed
Title | Date | PubMed |
---|---|---|
Detection of nandrolone, testosterone, and their esters in rat and human hair samples. | 1999 Oct |
|
[Treatment of acute purulent mediastinitis]. | 2001 |
|
Consequence of boar edible tissue consumption on urinary profiles of nandrolone metabolites. II. Identification and quantification of 19-norsteroids responsible for 19-norandrosterone and 19-noretiocholanolone excretion in human urine. | 2001 |
|
15N NMR relaxation studies of backbone dynamics in free and steroid-bound Delta 5-3-ketosteroid isomerase from Pseudomonas testosteroni. | 2001 Apr 3 |
|
Gas chromatography-combustion-isotope ratio mass spectrometry analysis of 19-norsteroids: application to the detection of a nandrolone metabolite in urine. | 2001 Aug 15 |
|
Advances in male hormonal contraception. | 2001 Dec |
|
Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints. | 2001 Dec |
|
Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. | 2001 Dec |
|
Expression of the human androgen receptor in eukaryotic cells using a recombinant adenovirus vector yields high levels of the soluble, functional receptor protein. | 2001 Dec |
|
The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. | 2001 Jan |
|
Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. | 2001 May |
|
Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest. | 2001 May 30 |
|
Drugs and food supplements in sports. The nandrolone lessons. | 2001 Oct |
|
Validity of radioimmunological methods for determining free testosterone in serum. | 2001 Sep |
|
Mass spectrometric characterization of the human androgen receptor ligand-binding domain expressed in Escherichia coli. | 2001 Sep 11 |
|
Effect of combined treatment with nandrolone and cocaine on the NMDA receptor gene expression in the rat nucleus accumbens and periaqueductal gray. | 2002 |
|
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. | 2002 Apr |
|
Randomized prospective comparison between erythropoietin and androgens in CAPD patients. | 2002 Apr |
|
Effects of withdrawal from anabolic androgenic steroids on aggression in adult male rats. | 2002 Apr 1 |
|
The popliteal-artery entrapment syndrome in a patient using anabolic steroids. | 2002 Apr 18 |
|
The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. | 2002 Aug 20 |
|
Physical provocation potentiates aggression in male rats receiving anabolic androgenic steroids. | 2002 Feb |
|
Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. | 2002 Feb |
|
Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin. | 2002 Feb |
|
Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. | 2002 Jan |
|
Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control. | 2002 Jan 25 |
|
Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men. | 2002 May |
|
Synthesis of nitrile derivatives of estrogens. | 2002 Oct 21 |
|
Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin. | 2002 Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/nandrolone.html
50 to 100 mg per week (women)
100 to 200 mg per week (men)
For children from 2 to 13 years of age, the average dose is 25 to 50 mg every 3 to 4 weeks.
Route of Administration:
Intramuscular
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:45:46 GMT 2023
by
admin
on
Fri Dec 15 17:45:46 GMT 2023
|
Record UNII |
WVJ22FFN83
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m7720
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | Merck Index | ||
|
Nandrolone dodecanoate
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | |||
|
26490-31-3
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | |||
|
DTXSID80949362
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | |||
|
300000029173
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | |||
|
247-739-7
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | |||
|
WVJ22FFN83
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY | |||
|
94371
Created by
admin on Fri Dec 15 17:45:46 GMT 2023 , Edited by admin on Fri Dec 15 17:45:46 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |